AU3553489A - Novel compounds and treatment - Google Patents

Novel compounds and treatment

Info

Publication number
AU3553489A
AU3553489A AU35534/89A AU3553489A AU3553489A AU 3553489 A AU3553489 A AU 3553489A AU 35534/89 A AU35534/89 A AU 35534/89A AU 3553489 A AU3553489 A AU 3553489A AU 3553489 A AU3553489 A AU 3553489A
Authority
AU
Australia
Prior art keywords
treatment
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35534/89A
Inventor
Derek Richard Buckle
Frederick Cassidy
David Glynn Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888810929A external-priority patent/GB8810929D0/en
Priority claimed from GB888825508A external-priority patent/GB8825508D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU3553489A publication Critical patent/AU3553489A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
AU35534/89A 1988-05-09 1989-05-09 Novel compounds and treatment Abandoned AU3553489A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888810929A GB8810929D0 (en) 1988-05-09 1988-05-09 Novel compounds
GB8810929 1988-05-09
GB888825508A GB8825508D0 (en) 1988-11-01 1988-11-01 Novel compounds
GB8825508 1988-11-01

Publications (1)

Publication Number Publication Date
AU3553489A true AU3553489A (en) 1989-11-29

Family

ID=26293868

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35534/89A Abandoned AU3553489A (en) 1988-05-09 1989-05-09 Novel compounds and treatment

Country Status (4)

Country Link
EP (1) EP0373204A1 (en)
JP (1) JPH03500542A (en)
AU (1) AU3553489A (en)
WO (1) WO1989010925A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618007B2 (en) * 1987-06-23 1991-12-12 Sanofi 2,2-dimethylchroman-3-ol derivatives, process for their preparation and pharmaceutical compositions in which they are present
AU658189B2 (en) * 1991-06-14 1995-04-06 Nippon Kayaku Kabushiki Kaisha Chroman derivatives

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3837809A1 (en) * 1988-11-08 1990-05-10 Merck Patent Gmbh tetralin
US5095016A (en) * 1989-08-11 1992-03-10 Kaken Pharmaceutical Co., Ltd. Benzopyran compounds, processes for their production and pharmaceutical compositions
WO1991009031A1 (en) * 1989-12-11 1991-06-27 Beecham Group Plc Trifluoromethyl substituted compounds and a pharmaceutical composition
US5250547A (en) * 1991-08-29 1993-10-05 Syntex (U.S.A.) Inc. Benzopyran derivatives
US5240943A (en) * 1991-12-19 1993-08-31 G. D. Searle & Co. Benzopyran class iii antiarrhythmic agents
US7230025B2 (en) 2002-09-26 2007-06-12 Pfizer, Inc. Pyrazole derivatives
MXPA05003195A (en) * 2002-09-26 2005-06-08 Pfizer Pyrazole derivatives as reverse transcriptase inhibitors.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
DE3726261A1 (en) * 1986-12-23 1988-07-07 Merck Patent Gmbh CHROME DERIVATIVES
IL86798A (en) * 1987-06-23 1992-12-01 Sanofi Sa 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
DE3732146A1 (en) * 1987-09-24 1989-04-06 Merck Patent Gmbh AZACHROMANDERIVATIVES
FR2621587B1 (en) * 1987-10-12 1990-02-09 Sanofi Sa 2,2-DIMETHYL CHROMENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
DE3811017A1 (en) * 1988-03-31 1989-10-19 Hoechst Ag UNSATURATED N-BENZOPYRANYLLACTAME
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618007B2 (en) * 1987-06-23 1991-12-12 Sanofi 2,2-dimethylchroman-3-ol derivatives, process for their preparation and pharmaceutical compositions in which they are present
AU658189B2 (en) * 1991-06-14 1995-04-06 Nippon Kayaku Kabushiki Kaisha Chroman derivatives

Also Published As

Publication number Publication date
EP0373204A1 (en) 1990-06-20
WO1989010925A1 (en) 1989-11-16
JPH03500542A (en) 1991-02-07

Similar Documents

Publication Publication Date Title
AU1676588A (en) Treatment of materials
AU4620789A (en) Treatment of obesity
AU3072989A (en) Skin treatment composition
AU3084389A (en) Acne treatment
AU3731489A (en) Pulp treatment methods
AU621673B2 (en) Fabric treatment
AU624518B2 (en) Material treatment
AU6386390A (en) Therapeutic necleosides
AU3604289A (en) Treatment of arthritis
AU4553089A (en) Fabric treatment composition
AU1279788A (en) Compounds and treatment
AU3553489A (en) Novel compounds and treatment
AU6660090A (en) Treatment of depression
AU8269787A (en) Flyslag treatment
GB8810748D0 (en) Novel treatment
AU4019489A (en) Surface treatment
AU3723589A (en) Therapeutic composition
AU4603289A (en) Novel treatment
AU4553189A (en) Fabric treatment composition
AU4102789A (en) Treatment compositions
AU2982289A (en) New methods and related compounds
AU4093789A (en) Transermal therapeutic composition
AU4000489A (en) Phenylalkylthiophenes and related compounds
AU3548789A (en) Timer
AU4476889A (en) Grain treatment